Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Calcium-independent lectin displaying mannose-binding specificity and able to maintain carbohydrate recognition activity in an acidic environment. Additionally we are shipping REG4 Kits (36) and REG4 Proteins (19) and many more products for this protein.
Showing 10 out of 34 products:
Human Polyclonal REG4 Primary Antibody for ELISA - ABIN1998393
Rafa, Dessein, Devisme, Buob, Truant, Porchet, Huet, Buisine, Lesuffleur: REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells. in International journal of oncology 2010
Study demonstrated that REG4, which is overexpressed in pancreatic ductal adenocarcinoma and secreted by cancer cells, promoted macrophage polarization to M2, through at least in part, activation of ERK1/2 (show MAPK1/3 Antibodies) and CREB (show CREB1 Antibodies).
REG4 is a transcriptional target of GATA6 (show GATA6 Antibodies) and is essential for colorectal tumorigenesis.
This study identifies REG4 as a potential serum biomarker for histotype-specific detection of mucinous ovarian cancer and suggests serum REG4 measurement as a non-invasive diagnostic tool for follow-up of patients with mucinous ovarian cancer.
aberrant REG4 expression plays an essential role in early ovarian carcinogenesis and is closely linked to mucinous ovarian tumors, differentiation and adverse prognosis of ovarian cancer by modulating proliferation, apoptosis, migration and invasion.
REG4 expression associated with favorable clinicopathological parameters and with higher overall survival from non-mucinous
The Reg IV may be involved in the finetuning of functions exerted by the neuroendocrine cells in the GI-tract.
Colorectal tumor patients with Reg4- and MMP-7 (show MMP7 Antibodies)-positive tumors had extremely poor overall survival.
High expression of REG4 is associated with poor therapeutic response, adverse outcome and an aggressive phenotype in rectal cancer patients treated with neoadjuvant chemoradiotherapy.
miR (show MLXIP Antibodies)-24 functions as a novel tumor suppressor in gastric cancer, and the anti-oncogenic activity may involve its inhibition of the target gene REG4.
REG4 expression is common in mucinous borderline ovarian tumors of the intestinal type as it is absent in the endocervical-like form tumors.
data suggest that Reg4 may protect against acinar cell necrosis in experimental pancreatitis by enhancing the expression of Bcl-2 (show BCL2 Antibodies) and Bcl-xL (show BCL2L1 Antibodies) via activation of the EGFR (show EGFR Antibodies)/Akt (show AKT1 Antibodies) signalling pathway.
Reg IV as an important modulator of gastrointestinal cell susceptibility to irradiation; hence, it is a potential target for adjunctive treatments for human colorectal cancer and other gastrointestinal malignancies.
reg4 is amplified in the early stages of pancreatic cancer development
Cloning and characterization of human REG4/RELP, in addition to cloning of mouse Reg4.
Calcium-independent lectin displaying mannose-binding specificity and able to maintain carbohydrate recognition activity in an acidic environment. May be involved in inflammatory and metaplastic responses of the gastrointestinal epithelium (By similarity).
, regenerating islet-derived protein 4
, REG-like protein
, gastrointestinal secretory protein
, reg IV
, regenerating gene type IV
, regenerating islet-derived protein IV